XBiotech Inc. — Director's Dealing 2016

Mar 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2016-03-17

Reporting Person: SIMARD JOHN (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-17	Common Shares	O	500000	$10.00	Disposed	6153267	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-17	Option to sell	$10.00	O	500000	Disposed	2016-03-20	Common Stock (500000)	Direct

Footnotes

F1: On March 17, 2016, Thorpe McKenzie exercised his option to purchase 500,000 shares of the Reporting Person's common stock at a purchase price of $10 per share.

F2: On March 20, 2014, the Reporting Person sold to Thorpe McKenzie an option to purchase 500,000 shares of his common stock at a purchase price of $10 per share, which option is exercisable for a period of two years from the grant date.